Unlock the future of weight management as we dive into the Retatrutide UK price landscape—a game-changing triple agonist peptide generating massive buzz. From private clinics to online pharmacies, discover how this cutting-edge therapy is becoming more accessible across the country without breaking the bank.
Understanding the Cost of Retatrutide in the UK Market
Navigating the cost of Retatrutide in the UK requires a clear-eyed look at a rapidly shifting market. As a next-generation obesity and diabetes treatment, its pricing is not yet standardized, often varying wildly between private clinics and online pharmacies. Patients must understand that a month’s supply, depending on dosage, can range from £250 to over £500, placing it at a premium compared to established GLP-1 drugs. This high entry price is driven by limited availability and the drug’s experimental status, though early adopters are already reporting significant results. The key is to compare total cost—including initial consultation fees and shipping—rather than just the vial price. By doing diligent research, you can find a provider that balances affordable access with legitimate medical oversight, turning a substantial investment into a life-changing tool for weight management.
What Determines the Price Tag of This Novel Treatment
Understanding the cost of Retatrutide in the UK market requires clarity on three key factors driving its price. As a next-generation triple agonist, this novel therapy commands a premium over existing GLP-1 medications due to its advanced mechanism and limited supply. Pricing for Retatrutide in the UK typically ranges from £200 to £350 per monthly course through private clinics, with costs influenced by dosage strength and consultation fees. Key considerations include:
- Initial consultation charges (£100–£250) which are non-refundable.
- Prescription-only access via regulated pharmacies—no legitimate OTC sales exist.
- Potential price reductions if purchased in multi-month supply bundles.
Patients should budget for ongoing monitoring appointments, as clinical oversight remains mandatory for safe use. While NHS coverage remains unconfirmed pending final approvals, private providers offer immediate access at these competitive rates.
Comparing Retatrutide Pricing with Other GLP-1 Agonists
Understanding the cost of Retatrutide in the UK market requires navigating a complex landscape of clinical trial availability and future private pricing. As a triple-hormone agonist still under investigation, it is not yet approved for general prescription, meaning current access is limited to studies. Once launched, the tiered pricing structure for weight loss injections will likely place it at a premium, influenced by manufacturing costs and demand. Key cost factors include:
- Clinical trial funding – Participants currently receive it free, but supply is restricted.
- Private clinic markups – After approval, prices could range from £200–£400 monthly, similar to Mounjaro.
- NHS coverage uncertainty – Strict eligibility criteria may limit public funding to severe obesity cases.
Q&A: Is Retatrutide cheaper than semaglutide? Likely not initially—until generic competition emerges, expect a higher price due to advanced mechanism and novelty.
Why Costs Vary Between Online Pharmacies and Local Clinics
Navigating the cost of Retatrutide in the UK market reveals a premium pricing structure driven by its clinical promise and limited availability. As a novel triple-hormone agonist still under evaluation, private clinics and compounding pharmacies set prices significantly higher than standard weight-loss medications, often ranging from £250 to £450 per month. This dynamic landscape demands that patients weigh financial commitment against efficacy.
Retatrutide’s cost is not just a number—it is an investment in cutting-edge metabolic science, reflecting its rarity and potential for unprecedented weight reduction.
Key financial considerations include:
- Consultation fees: Private endocrinologist consultations can add £150–£300 upfront.
- Titration phases: Lower starting doses reduce monthly spend initially.
- Online vs. in-clinic: Telehealth providers often offer bundled packages for cost efficiency.
Smart comparison shopping and reviewing for genuine pharmacy accreditations remain essential to avoid counterfeit products and hidden costs in this volatile market.
Where to Source Retatrutide in the United Kingdom
For sourcing Retatrutide in the United Kingdom, regulated online pharmacies registered with the General Pharmaceutical Council (GPhC) are the most reliable and legal pathway, as they dispense only after a valid prescription from a UK-based clinician. Avoid unverified peptide vendors or social media resellers, which pose significant risks of counterfeit products or safety violations. Reputable UK suppliers like Manual, Numan, or Zava typically require an online consultation with a healthcare professional to assess suitability before providing the medication. For research-grade vials, verified biotech suppliers such as BioVendor or Cambridge Bioscience offer certified purity, though these are intended only for laboratory use, not self-administration. Always prioritize legality and safety over convenience when acquiring this GLP-1 agonist.
Registered Online Pharmacies Offering Competitive Rates
If you’re looking for Retatrutide in the UK, your first and only responsible stop should be a regulated medical consultation. This GLP-1 peptide is still in clinical trials, so it’s not yet approved as a standard NHS or private prescription medicine. The most reliable path is through a reputable, GPhC-registered online pharmacy or a specialist weight management clinic that offers access to clinical trials. Avoid unregulated peptide vendors or social media sellers, as these sources lack quality control and could expose you to dangerous counterfeit products. Finding legitimate Retatrutide in the UK requires a prescription through clinical trial enrollment.
Private Weight Loss Clinics and Their Fee Structures
For those seeking Retatrutide in the United Kingdom, sourcing this research peptide requires navigating strict regulatory frameworks, as it is not yet approved for human use by the MHRA. Licensed UK peptide suppliers offer the compound strictly for laboratory research, not personal consumption. To find legitimate vendors, focus on companies that provide third-party Certificate of Analysis (CoA) and clear purity specifications. Reputable UK-based outlets include sites like Peptide Sciences (international shipping) or Pharma Grade UK, but always verify their batch-testing protocols. Always consult a qualified medical https://retatrutide.uk.com/ professional before considering any unlicensed substance. For reliable options, consider this checklist: verify company registration with Companies House, confirm UK-based customer support, check for independent lab reports, and read user reviews on dedicated forums like PeptideTalk. Avoid sellers without transparent sourcing or those offering immediate human-use claims; many counterfeit or under-dosed samples circulate in unregulated markets.
NHS Availability and Public Healthcare Access
For sourcing Retatrutide in the United Kingdom, the safest and most reliable pathway is through a registered private telehealth provider or a regulated compounding pharmacy that requires a valid prescription. As Retatrutide is not yet widely available on the NHS for weight management (typically reserved for clinical trials or specific metabolic conditions), private clinics offering specialist obesity or endocrinology consultations are your primary option. These providers will conduct a thorough medical assessment, including blood work, to confirm suitability before issuing a prescription. Sourcing Retatrutide from UK registered pharmacies is critical to avoid counterfeit or improperly stored peptides. Beware of unregulated online marketplaces or social media vendors, as these pose significant risks of contamination or incorrect dosing.
Never purchase Retatrutide from any source that does not require a prescription and a face-to-face or video consultation with a UK-registered doctor.
If you are eligible for a clinical trial, the UK’s national health research database (Be Part of Research) can direct you to approved sites at academic hospitals. For self-funding, expect to pay between £150–£300 per month, inclusive of the drug and consultation fees. Always verify the pharmacy’s registration with the General Pharmaceutical Council (GPhC) before committing to any purchase.
Factors Influencing the Final Amount You Pay
The final amount you pay for anything hinges on a mix of obvious and hidden factors. The base price is just the start; sales tax and shipping costs significantly inflate the total, especially for larger purchases. Dynamic pricing, often adjusted by algorithms based on demand or your browsing history, can also spike costs without warning. Don’t forget add-ons like warranties, service fees, or convenience charges for booking online. Coupons and loyalty discounts can slash the price, but they usually expire quickly. For services, hidden fees like “processing” or “resort” charges often appear at checkout. Ultimately, comparing the final price—not the sticker price—is key to avoiding surprises.
Dosage Strength and Treatment Duration Impact on Spending
The final amount you pay for almost anything is rarely just the sticker price. Understanding hidden costs for services is key to avoiding surprises. Several key factors play a role, including taxes, which vary by location, and any mandatory service fees or gratuities. For big purchases, interest rates on loans can significantly increase your total, while shipping and handling costs add to online orders. Don’t forget about potential add-ons, like extended warranties or premium upgrades, that quickly inflate the final bill. You might also encounter dynamic pricing, where the cost changes based on demand or your browsing history.
Geographical Price Differences Across England, Scotland, and Wales
The final amount you pay is rarely the sticker price, as several key factors directly inflate or reduce your total cost. Understanding total cost of ownership is crucial for smart budgeting. Your principal sum is just the starting point; interest rates, whether fixed or variable, compound the debt over time. Never overlook hidden fees for processing, late payments, or annual maintenance, which can silently drain your wallet. Additionally, the loan or contract term length dramatically alters your payoff: a shorter term means higher monthly payments but lower total interest, while extended terms reduce monthly burdens yet skyrocket the overall amount. Taxes, insurance premiums, and any mandatory add-ons like extended warranties further increase the figure. To control your final cost, always negotiate the rate and scrutinize every fee structure before signing.
Discounts, Loyalty Programs, and Bulk Purchase Options
The final amount you pay for almost anything depends on a handful of key factors that can quietly nudge the price up or down. Total cost of ownership matters most—think ongoing fees, maintenance, and fuel for a car, or subscription costs for a service. Then there’s the base price, which fluctuates with supply, demand, and seasonal timing. Don’t forget taxes and shipping fees, which often sneak in at checkout, plus any optional extras like warranties or faster delivery. Bulk buying or using a discount code can lower your total, while interest on credit pushes it higher. Small choices at purchase can double your final bill without you noticing.
Hidden Expenses Beyond the Medication Itself
When you pick up a prescription, the price tag on the bottle is just the beginning. Hidden expenses beyond the medication itself often sneak up on you, turning a manageable cost into a budget-buster. First, there are doctor visits—many specialists charge separate fees for check-ins or prior authorizations your insurance demands. Then, you’ve got travel costs: gas for pharmacy runs, parking fees at the clinic, or even missed work hours. Don’t forget supplies like syringes, pill organizers, or special food restrictions if the drug interacts with dairy. Some meds require regular lab tests or monitoring devices, which aren’t cheap. Finally, subscription services for delivery or tracking apps add another layer. Before you know it, your “free” generic can cost you a hundred bucks in side expenses.
Q: How can I avoid these hidden costs when starting a new medication?
A: Ask your doctor upfront if prior authorization is needed, check if your pharmacy offers free delivery, and see if your insurance covers required lab work. Also, negotiate a generic alternative—it often means fewer monitoring requirements and cheaper supplies.
Consultation Fees and Prescription Charges
Beyond the price tag of a prescription, hidden expenses silently inflate healthcare costs. Managing chronic care costs requires anticipating fees for diagnostic tests, specialist consultations, and ongoing monitoring to adjust dosages. Patients often overlook ancillary supplies, such as syringes, testing strips, or specialized delivery devices, which are rarely included. Additionally, travel costs for frequent appointments, lost wages from treatment-related downtime, and higher insurance premiums with restrictive formularies create a significant financial burden. These cumulative expenses can exceed the drug’s list price, making comprehensive budgeting essential for true affordability.
Shipping Costs and Delivery Timelines
The label price of a prescription rarely tells the full story, as hidden medication costs often outweigh the drug itself. Patients frequently face inflated physician visit fees for refill authorizations, laboratory monitoring for liver or kidney function, and specialized pharmacist consultations for complex regimens. Transportation to appointments, time off work, and childcare add unexpected financial strain. For chronic conditions, these ancillary costs can total hundreds of dollars monthly.
Consider the following hidden expenses that catch many off guard:
- Dedicated pill organizers, refrigeration units for biologics, or specialized disposal supplies
- Over-the-counter adjuncts like electrolyte solutions or anti-nausea aids
- Deductible resets mid-year that shift cost-sharing obligations overnight
Co-pay accumulators and pharmacy benefit manager clawbacks further distort real out-of-pocket totals, making each refill cycle a potential surprise. Ignoring these peripheral burdens can derail consistent treatment adherence.
Follow-Up Appointments and Monitoring Expenses
Prescription costs are just the tip of the iceberg. Hidden expenses often include pharmacy dispensing fees, which can vary wildly between stores, and the cost of specialized delivery if you can’t pick it up yourself. You might also need to buy over-the-counter supplies like syringes, pill organizers, or acidity reducers to manage side effects. Managing the total cost of medication means budgeting for these add-ons. For example:
- Co-pays for follow-up doctor visits to monitor drug effectiveness.
- Lost wages from time off work to pick up or take the medication.
- Higher health insurance premiums if your plan changes.
These small items quickly add up, turning a manageable script into a real financial headache.
Insurance Coverage and Reimbursement Possibilities
Navigating the landscape of insurance coverage can feel like a complex puzzle, yet understanding your policy is the first step toward financial security. Many health plans now offer robust reimbursement possibilities for a wide array of medical services, from preventive care to specialist visits. To maximize these benefits, always verify that your provider is in-network, which typically lowers out-of-pocket costs. Maximizing your health plan benefits requires proactive management, including submitting detailed claims for eligible expenses like prescription drugs or physical therapy. Don’t overlook flexible spending accounts or health savings accounts, which provide tax-advantaged ways to pay for uncovered costs. By staying informed about your deductible and co-pay structures, you can transform a confusing system into a powerful tool for managing healthcare expenses efficiently and securing the coverage you deserve.
Private Health Insurance Policies Including This Drug
Navigating health insurance coverage limits can feel like decoding a secret language, but unlocking reimbursement possibilities often starts with verifying your specific plan’s out-of-network benefits. Many policies offer partial repayment for services from non-contracted providers, though you’ll typically need to meet a deductible first. For prescription drugs, tiered formularies dictate what percentage you pay, while durable medical equipment may require prior authorization for full coverage. Understanding whether you have a copay, coinsurance, or a Health Savings Account (HSA) drastically changes your financial strategy. Many forget that preventive screenings like mammograms are often fully covered with zero out-of-pocket costs under the Affordable Care Act. To maximize your claims:
- Always confirm your provider’s network status before any procedure.
- Submit itemized receipts promptly to avoid denied reimbursement deadlines.
- Appeal any denial in writing, citing your policy’s specific language.
This proactive approach transforms confusing coverage fine print into tangible financial leverage.
Self-Pay vs. Insurance: Total Cost Comparison
Insurance coverage for medical and property-related expenses varies significantly by policy type, provider, and jurisdiction. Reimbursement possibilities typically depend on whether a service is deemed medically necessary or a covered loss. Understanding your policy’s deductible, copay, and out-of-pocket maximum is essential for financial planning. Claims for reimbursement often require submission of detailed documentation, including invoices and diagnosis codes, within a specified timeframe. Common avenues include direct billing between the insurer and provider, or patient-initiated claims for out-of-network care.
Always pre-verify coverage for elective or high-cost procedures to avoid unexpected denial.
Coverage categories generally include:
- Health insurance (inpatient, outpatient, prescription drugs)
- Property and casualty (home, auto, liability)
- Disability and life insurance (income replacement, death benefits)
Tax Implications for Medical Expenses
Navigating insurance coverage for investigative procedures can feel complex, but medical necessity documentation is your strongest tool for securing reimbursement. Private insurers, including PPOs and HMOs, typically cover costs when a physician provides clear diagnostic justification, while Medicare often requires precertification for advanced imaging like MRI or CT scans. For uncovered services, consider these reimbursement possibilities:
- Out-of-network appeals – Challenge denials with supporting letters from specialists.
- Flexible spending accounts (FSAs) – Use pre-tax dollars for eligible deductibles or copays.
- Cash-pay discounts – Some facilities offer reduced rates for self-pay patients.
Always verify your specific plan’s exclusions to avoid surprise balances.
Pricing Trends for Retatrutide in 2025 and Beyond
Looking ahead to 2025 and beyond, pricing for Retatrutide will likely follow a tiered strategy reflecting its advanced triple-receptor mechanism. As a once-weekly injectable for obesity and type 2 diabetes, initial list prices may exceed those of semaglutide, potentially reaching $1,200–$1,500 per month before insurance. However, strategic market access will hinge on securing broad formulary coverage; intense competition from oral and dual-agonist alternatives should drive rebates and patient-assistance programs. Expect significant price erosion by 2027 as biosimilars and direct-to-consumer telehealth models emerge. For cost-conscious prescribers, value-based contracting tied to real-world weight-loss outcomes will be the key to optimizing net pricing and patient affordability. Ultimately, early adopters should negotiate contracts with volume-based discounts and step-therapy exemptions to avoid lock-in at premium rates.
Patent Expirations and Generic Entry Effects
Retatrutide pricing in 2025 and beyond is poised for a strategic recalibration, driven by intense market competition and expanding clinical indications. As a triple-agonist surpassing semaglutide in efficacy, its initial launch price is expected to hover around $1,200–$1,500 per month, mirroring established GLP-1 tiers, but aggressive payer negotiations and biosimilar threats will force a 20–30% reduction by 2027. This positions retatrutide pricing trends as a high-stakes race between premium innovation and accessible mass adoption. Key factors include:
- Patent Exclusivity: Eli Lilly’s IP fortress delays generics until late next decade, sustaining premium pricing.
- Volume vs. Margin: Obesity-label expansion will trade high margins for massive prescription volume.
- Global Access: Lower-income nation tiered pricing will carve 40–50% discounts versus U.S. list prices.
Q: Will insurance cover retatrutide for weight loss by 2026?
A: Yes, but only for BMI ≥30 or with comorbidities, as Medicare and large plans accept obesity as a chronic disease costing the system billions. Expect step therapy prior authorization hurdles.
Market Competition Driving Down Costs
By 2025, Retatrutide pricing is expected to stabilize as more manufacturers enter the market, driving down costs for this next-gen triple-agonist drug. While early access may still be expensive—around $800 to $1,200 monthly without insurance—generic competition and bulk production could slash prices by up to 30% by 2027. Retatrutide cost reduction will heavily rely on insurance coverage expansions and pharmacy benefit negotiations. Key factors include:
- Patent expirations for related GLP-1 drugs lowering baseline costs.
- Increased production scale from multiple pharmaceutical companies.
- Potential for government price caps on obesity medications.
For patients, the sweet spot likely arrives in 2026–2028, when discount programs and biosimilars make it more accessible. Stay tuned for coupon savings if your plan doesn’t cover it yet.
Regulatory Changes Affecting UK Pharmaceutical Pricing
As the next-generation obesity and diabetes treatment moves beyond clinical trials, pricing trends for Retatrutide in 2025 and beyond are being shaped by fierce market competition and manufacturing scale. Early projections suggest a list price between $1,200 and $1,500 per month, roughly comparable to existing GLP-1s, though aggressive payer negotiations and biosimilar entry could drive discounts of 20–40% by 2027. Market access strategies will likely pivot on the drug’s triple-receptor efficacy, justifying a premium for patients who plateau on semaglutide. Yet, the true price story may be written not in pharmacy shelves, but in long-term health system savings. Key factors driving cost include:
- Supply chain investments for peptide synthesis
- Competition from Novo Nordisk, Eli Lilly, and early-stage biosimilars
- Insurance coverage tied to weight-loss outcomes
Smart Strategies to Afford This Treatment
Exploring smart strategies to afford this treatment can significantly reduce financial strain. Start by verifying if your health insurance plan covers the procedure under its medical necessity or preventive care clauses. Many clinics offer payment plans or sliding-scale fees based on income, so always ask about financial assistance programs. Consider using a Health Savings Account (HSA) or Flexible Spending Account (FSA) to pay with pre-tax dollars. For elective treatments, comparing costs across multiple providers may reveal lower prices without sacrificing quality. Some pharmaceutical or device manufacturers also provide patient assistance programs or discounts. Finally, third-party medical credit cards like CareCredit can spread payments over time, often with deferred interest if paid promptly.
Q: What if my insurance denies coverage?
A: File an appeal with a detailed letter of medical necessity from your doctor, and request a peer-to-peer review. If denied again, ask the provider’s billing office for cash-pay discounts or charity care options.
Price Matching and Price Alerts from Reputable Sellers
When the cost of this treatment felt insurmountable, Maria shifted her approach from despair to determination. She discovered affordable medical financing options that transformed her outlook. Instead of paying upfront, she leveraged a zero-interest payment plan spread over twelve months. She also contacted the manufacturer directly, securing a patient assistance program that covered half the cost after a simple application. To bridge the remaining gap, Maria opened a dedicated health savings account and contributed monthly, earning tax-free growth. Her final smart move was asking the clinic about a cash-pay discount, which saved her an additional 15%. By combining these strategies—from flexible financing to manufacturer aid—she turned an impossible bill into a manageable monthly commitment, proving that with a little research, advanced care can become accessible.
Using Prescription Savings Cards and Vouchers
Unlocking access to high-cost care begins with proactive financial planning. A smart medical financing strategy involves exploring payment plans offered directly by clinics, which often break large bills into manageable monthly installments without high interest. Leveraging a Health Savings Account (HSA) or Flexible Spending Account (FSA) lets you use pre-tax dollars, immediately reducing your out-of-pocket burden. For significant procedures, consider medical credit cards like CareCredit, but prioritize zero-interest promotional periods to avoid debt traps. Additionally, always negotiate the cash-pay price upfront, as providers frequently offer discounts for lump-sum payments. Finally, investigate manufacturer copay assistance programs or non-profit patient advocacy groups that provide grants. Combining these methods—from installment plans to tax-advantaged accounts—creates a dynamic, customized approach to affording essential treatments without crippling your finances.
Negotiating with Clinics for Better Rates
Affordable treatment options are within reach through strategic financial planning. Start by verifying your insurance benefits for coverage details and out-of-network allowances. If gaps remain, negotiate a cash-pay discount directly with the provider; many clinics offer 10–30% reductions for upfront payments. Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) let you use pre-tax dollars, effectively lowering your total cost. For larger expenses, consider a 0% APR medical credit card or a personal loan with a fixed rate. Explore manufacturer patient assistance programs and condition-specific nonprofits—these often provide grants or co-pay relief. Combining these approaches creates a manageable, debt-light path to necessary care.
Patient Experiences with Retatrutide Costs
For many patients, the sticker shock of Retatrutide costs has been a major hurdle, especially since it’s not yet FDA-approved for weight loss. Affordable Retatrutide options are scarce, with clinical trial participants getting it free, but those seeking it off-label through compounding pharmacies or research peptides often paying $200 to $600 monthly. Some folks have shared online that splitting custom doses from a single vial feels like a risky workaround, but it’s the only way they can afford it. Insurance rarely covers it unless prescribed for diabetes, leaving patients to either drain savings or hunt for discount cards. Managing Retatrutide treatment costs usually means comparing prices across several suppliers, which feels like a part-time job. The hope is that broader approval will eventually drive prices down, but for now, it’s a steep financial climb for those chasing metabolic health.
Real Anecdotes from UK Users on Monthly Outlay
Patients navigating retatrutide costs report a stark divide between clinical promise and financial reality. Affordability of retatrutide remains the primary barrier for most individuals, with out-of-pocket expenses often exceeding $1,000 monthly without insurance coverage. Many describe frustrating prior-authorization battles, as insurers classify it as investigational, while others turn to manufacturer coupons that offer only temporary relief. Common patient-reported challenges include:
- Unexpected pharmacy rejections due to step-therapy requirements.
- Hidden fees from compounding pharmacies claiming lower prices.
- Delayed treatment cycles to stretch budgets.
No patient should have their weight-loss journey halted by unaffordable drug pricing. Those who secure coverage through employer plans or Medicare Part D trials report the most consistent access, yet high deductibles still force difficult trade-offs. For sustainable management, proactive negotiation with healthcare teams and robust advocacy for payer inclusion are non-negotiable steps. The value of retatrutide’s efficacy is clear—but without cost solutions, it remains out of reach for many who need it most.
Common Mistakes That Increase Your Final Bill
Patients report that Retatrutide costs, while initially daunting due to lack of insurance coverage, are often offset by its unprecedented efficacy for weight loss and metabolic health. Early adopters emphasize that the significant out-of-pocket expense, typically ranging from $800 to $1,200 monthly, is frequently justified by dramatic reductions in body weight and improved blood sugar control that surpass older GLP-1 medications. Affordable Retatrutide access remains a primary barrier, with many patients securing savings through manufacturer coupons, clinical trial enrollments, or compounding pharmacy alternatives. However, feedback consistently warns against prioritizing cost over medical supervision, as side effects require careful dose titration. For those who can navigate the financial hurdle, the consensus is clear: the transformative health outcomes create a positive value proposition that makes the investment worthwhile.
Success Stories of Affordable Access
Patients exploring retatrutide often express concern about its high out-of-pocket costs, as the medication is not yet FDA-approved for weight management or diabetes. Without insurance coverage, monthly expenses can range from hundreds to over a thousand dollars, prompting many to seek clinical trials or manufacturer savings programs for access. Managing retatrutide treatment costs requires careful financial planning. Key patient-reported hurdles include:
- Lack of insurance formularies listing the drug.
- Unpredictable pricing at different pharmacies.
- Difficulty obtaining prior authorization for off-label use.
Some individuals report switching to telehealth platforms that offer bundled pricing, but supply limitations and delayed shipments remain common frustrations. Overall, patient experiences underscore a gap between the drug’s efficacy and its affordability.
